Dissecting the Immune Landscape of Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a molecularly heterogeneous hematological malignancy with variable response to treatment. Recurring cytogenetic abnormalities and molecular lesions identify AML patient subgroups with different survival probabilities; however, 50–70% of AML cases harbor either normal...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidson-Moncada, Jan, Viboch, Elena, Church, Sarah E., Warren, Sarah E., Rutella, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316310/
https://www.ncbi.nlm.nih.gov/pubmed/30477280
http://dx.doi.org/10.3390/biomedicines6040110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316310/
https://www.ncbi.nlm.nih.gov/pubmed/30477280
http://dx.doi.org/10.3390/biomedicines6040110

Ejemplares similares